Search research articles
Contact Us
Filters
Showing results (991-1000 of 1,079) with videos related to
Page
of 108
Sort By:
Gynecologic Oncology
|
October 13, 2021
Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer
G E Konecny, A E Wahner Hendrickson, T M Davidson, et al.
The Journal of Experimental Medicine
|
July 31, 2013
Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood
Minji Byun, Cindy S Ma, Arzu Akçay, et al.
Immunity
|
October 22, 2013
Circulating precursor CCR7(lo)PD-1(hi) CXCR5⁺ CD4⁺ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure
Jing He, Louis M Tsai, Yew Ann Leong, et al.
The Journal of Allergy and Clinical Immunology
|
July 9, 2013
Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function
Megan L Ives, Cindy S Ma, Umaimainthan Palendira, et al.
Ebiomedicine
|
July 5, 2025
Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis
Matthew Lynch, Sophie Manoy, Peter D Sly, et al.
The Journal of Experimental Medicine
|
May 6, 2015
STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and function
Robert P Wilson, Megan L Ives, Geetha Rao, et al.
The Journal of Allergy and Clinical Immunology
|
February 10, 2019
Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4<sup>+</sup> T cells
Julia Bier, Geetha Rao, Kathryn Payne, et al.
The Journal of Clinical Investigation
|
December 8, 2020
Somatic reversion of pathogenic DOCK8 variants alters lymphocyte differentiation and function to effectively cure DOCK8 deficiency
Bethany A Pillay, Mathieu Fusaro, Paul E Gray, et al.
QJM : Monthly Journal of the Association of Physicians
|
October 21, 2022
Bacterial antibiotic resistance among cancer inpatients in China: 2016-20
Y Ju, K Liu, G Ma, et al.
The Journal of Experimental Medicine
|
October 19, 2011
DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice
Katrina L Randall, Stephanie S-Y Chan, Cindy S Ma, et al.
Page
of 108
Search research articles
Search
Showing results (991-1000 of 1,079) with videos related to
Sort By:
Page
of 108
Gynecologic Oncology
|
October 13, 2021
Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer
G E Konecny, A E Wahner Hendrickson, T M Davidson, et al.
The Journal of Experimental Medicine
|
July 31, 2013
Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood
Minji Byun, Cindy S Ma, Arzu Akçay, et al.
Immunity
|
October 22, 2013
Circulating precursor CCR7(lo)PD-1(hi) CXCR5⁺ CD4⁺ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure
Jing He, Louis M Tsai, Yew Ann Leong, et al.
The Journal of Allergy and Clinical Immunology
|
July 9, 2013
Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function
Megan L Ives, Cindy S Ma, Umaimainthan Palendira, et al.
Ebiomedicine
|
July 5, 2025
Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis
Matthew Lynch, Sophie Manoy, Peter D Sly, et al.
The Journal of Experimental Medicine
|
May 6, 2015
STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and function
Robert P Wilson, Megan L Ives, Geetha Rao, et al.
The Journal of Allergy and Clinical Immunology
|
February 10, 2019
Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4<sup>+</sup> T cells
Julia Bier, Geetha Rao, Kathryn Payne, et al.
The Journal of Clinical Investigation
|
December 8, 2020
Somatic reversion of pathogenic DOCK8 variants alters lymphocyte differentiation and function to effectively cure DOCK8 deficiency
Bethany A Pillay, Mathieu Fusaro, Paul E Gray, et al.
QJM : Monthly Journal of the Association of Physicians
|
October 21, 2022
Bacterial antibiotic resistance among cancer inpatients in China: 2016-20
Y Ju, K Liu, G Ma, et al.
The Journal of Experimental Medicine
|
October 19, 2011
DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice
Katrina L Randall, Stephanie S-Y Chan, Cindy S Ma, et al.
Page
of 108